Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.
Also called NCT01642134
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 124 participants
- Sponsor
- Andres Iñiguez Romo, MD, PhD
- Registry
-
NCT01642134 -
2011-005784-24
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT01642134. Randomized; single masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2019-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI
- Acronym
- AUREA
- Condition
- Aortic Valve Stenosis
- Condition
- Stroke
- Intervention (Drug)
- aspirin+clopidogrel (Duoplavin)
- Lead sponsor
- Andres Iñiguez Romo, MD, PhD
Record details
- Record id
cardio:ct-nct01642134- Content hash
34265dff8876d480efdba06760e74e118072a9d47fc96e5d8312da0ed87a2383